IN166581B - - Google Patents

Info

Publication number
IN166581B
IN166581B IN552/DEL/85A IN552DE1985A IN166581B IN 166581 B IN166581 B IN 166581B IN 552DE1985 A IN552DE1985 A IN 552DE1985A IN 166581 B IN166581 B IN 166581B
Authority
IN
India
Application number
IN552/DEL/85A
Other languages
English (en)
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN522/DEL/87A priority Critical patent/IN166590B/en
Publication of IN166581B publication Critical patent/IN166581B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN552/DEL/85A 1984-08-14 1985-07-15 IN166581B (xx)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN522/DEL/87A IN166590B (xx) 1984-08-14 1987-06-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001290 WO1986001107A1 (en) 1984-08-14 1984-08-14 Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making

Publications (1)

Publication Number Publication Date
IN166581B true IN166581B (xx) 1990-06-09

Family

ID=22182231

Family Applications (2)

Application Number Title Priority Date Filing Date
IN552/DEL/85A IN166581B (xx) 1984-08-14 1985-07-15
IN522/DEL/87A IN166590B (xx) 1984-08-14 1987-06-17

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN522/DEL/87A IN166590B (xx) 1984-08-14 1987-06-17

Country Status (24)

Country Link
US (1) US4656169A (xx)
EP (1) EP0173497B1 (xx)
JP (1) JPS6147486A (xx)
KR (1) KR870000624B1 (xx)
AT (1) ATE46162T1 (xx)
AU (1) AU553699B2 (xx)
CA (1) CA1255304A (xx)
DD (1) DD236529A5 (xx)
DE (1) DE3572818D1 (xx)
DK (1) DK366685A (xx)
ES (2) ES8704495A1 (xx)
FI (1) FI82695C (xx)
GR (1) GR851968B (xx)
IE (1) IE58123B1 (xx)
IL (1) IL76076A0 (xx)
IN (2) IN166581B (xx)
NO (1) NO164101C (xx)
NZ (1) NZ213085A (xx)
PH (1) PH22910A (xx)
PL (2) PL145221B1 (xx)
PT (1) PT80940B (xx)
WO (1) WO1986001107A1 (xx)
YU (1) YU44894B (xx)
ZA (1) ZA856102B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
WO1990002126A1 (en) * 1988-08-24 1990-03-08 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
TW202450B (xx) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4193996A (en) * 1979-04-04 1980-03-18 Pfizer Inc. Spiro-quinolone hydantoins
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
IE58123B1 (en) 1993-07-14
DK366685D0 (da) 1985-08-13
PL147875B1 (en) 1989-08-31
IN166590B (xx) 1990-06-09
ES551963A0 (es) 1988-02-16
PT80940A (en) 1985-09-01
DE3572818D1 (en) 1989-10-12
IE851991L (en) 1986-02-14
PT80940B (pt) 1987-12-30
FI82695B (fi) 1990-12-31
AU4612685A (en) 1986-02-20
DK366685A (da) 1986-02-15
GR851968B (xx) 1985-12-13
PL145221B1 (en) 1988-08-31
PL254960A1 (en) 1987-01-12
ES546093A0 (es) 1987-04-01
ZA856102B (en) 1987-03-25
NO861425L (no) 1986-04-11
FI861544A (fi) 1986-04-11
AU553699B2 (en) 1986-07-24
WO1986001107A1 (en) 1986-02-27
ES8704495A1 (es) 1987-04-01
ES8801831A1 (es) 1988-02-16
IL76076A0 (en) 1985-12-31
US4656169A (en) 1987-04-07
ATE46162T1 (de) 1989-09-15
KR870000624B1 (ko) 1987-03-26
CA1255304A (en) 1989-06-06
JPH0339512B2 (xx) 1991-06-14
NO164101C (no) 1990-08-29
PH22910A (en) 1989-01-24
YU129085A (en) 1988-04-30
NZ213085A (en) 1988-03-30
NO164101B (no) 1990-05-21
EP0173497A1 (en) 1986-03-05
DD236529A5 (de) 1986-06-11
PL261413A1 (en) 1988-01-21
KR860001811A (ko) 1986-03-22
YU44894B (en) 1991-04-30
FI82695C (fi) 1991-04-10
EP0173497B1 (en) 1989-09-06
JPS6147486A (ja) 1986-03-07
FI861544A0 (fi) 1986-04-11

Similar Documents

Publication Publication Date Title
DE3539674C2 (xx)
AT379850B (xx)
GR852087B (xx)
GR850051B (xx)
IN166581B (xx)
DE3590443T1 (xx)
DE3433108C2 (xx)
DE3438743C2 (xx)
GR851658B (xx)
AU2557584A (xx)
GR73375B (xx)
GR73484B (xx)
GR73803B (xx)
GR74646B (xx)
AU2219783A (xx)
BG45296A1 (xx)
BG45254A1 (xx)
BG38294A1 (xx)
BG39778A1 (xx)
BG44718A1 (xx)
BG45149A1 (xx)
BG44723A1 (xx)
BG44737A1 (xx)
BG45158A1 (xx)
BG44749A1 (xx)